Randomized phase ii study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer

HIGHLIGHTS

• who: Yutaka Ogata and colleagues from the Department of Surgery, Kurume University Medical Center, Kurume, Japan, Departments of Surgery have published the research: Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal Cancer, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0120064]. March 19, 2015 of March/17,/1998
• what: The aim was to determine the efficacy and toxicity of systemic administration of antineoplastons as an adjuvant added to 5-FU HAI after liver resection. This side . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.